
    
      Colorectal cancer is a common clinical gastrointestinal cancer. In addition to the early
      diagnosis of some patients, approximately 50% of patients have had distant metastases at the
      time of diagnosis. For patients with advanced colorectal cancer, systemic chemotherapy is the
      main treatment. We consider to add apatinib,a tyrosine kinase inhibitor of VEGF,to the
      therapy of these patients. We designed the study to explore the possibility of apatinib for
      Advanced Colorectal Cancer.
    
  